Efficacy and Safety of Dupilumab in Children Aged ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis
Saturday, April 23, 2022
1:30 PM – 1:45 PM US MT
Location: Convention Center: Mile High Ballroom 1AB
CE: Enduring CME: 0.25
Publication Number: 1435.3
Amy S. Paller, Northwestern University The Feinberg School of Medicine, Wilmette, IL, United States; Elaine C. Siegfried, Saint Louid University, St. Louis, MO, United States; Eric L. Simpson, Oregon Health & Science University, Portland, OR, United States; Yiping Sun, Regeneron, Basking Ridge, NJ, United States; Randy Prescilla, Sanofi-Aventis, Cambridge, MA, United States; John T. O'Malley, Sanofi, Wellesley, MA, United States; Ashish Bansal, Regeneron pharmaceuticals, Tarrytown, NY, United States
Presenting Author(s)
Deborah Griffis, PharmD
Associate Director Field Medical, Dermatology Regeneron Denver, Colorado, United States
Participants should be aware of the following financial/non-financial relationships:
Deborah Griffis, PharmD: Regeneron (Individual(s) Involved: Self; Products/Services: Employment with an ineligible company): Employee
Amy S. Paller, MD, MSc: ● abbvie (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● AbbVie (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Abeona Therapeutics (Currently Ongoing) (Products/Services: Consultant). ● Alcimed (Currently Ongoing) (Products/Services: Consultant). ● Almirall (Currently Ongoing) (Products/Services: Consultant). ● Amagma (Currently Ongoing) (Products/Services: Consultant). ● AnaptysBio (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Arena (Currently Ongoing) (Products/Services: Consultant). ● Azitra, (Currently Ongoing) (Products/Services: Consultant). ● Bausch (Currently Ongoing) (Products/Services: Advisory Committee). ● Catawba (Currently Ongoing) (Products/Services: Consultant). ● Dermira (Currently Ongoing) (Products/Services: Consultant). ● Eli Lilly (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Exicure (Currently Ongoing) (Products/Services: Consultant). ● Forte (Currently Ongoing) (Products/Services: Consultant). ● Galderma (Currently Ongoing) (Products/Services: Consultant). ● Incyte (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Kamari (Currently Ongoing) (Products/Services: Consultant). ● KrystalBio (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● LEO Pharma (Currently Ongoing) (Products/Services: Consultant). ● LifeMax (Currently Ongoing) (Products/Services: Consultant). ● NAOS (Currently Ongoing) (Products/Services: Consultant). ● Novartis (Currently Ongoing) (Products/Services: Consultant). ● Pfizer (Currently Ongoing) (Products/Services: Consultant). ● Phoenix (Currently Ongoing) (Products/Services: Consultant). ● Pierre Fabre Dermo-Cosmetics (Currently Ongoing) (Products/Services: Consultant). ● Regeneron Pharmaceuticals, Inc. (Currently Ongoing) (Products/Services: Consultant). ● Regeneron Pharmaceuticals, Inc. (Currently Ongoing) (Products/Services: Consultant). ● Sanofi Genzyme (Currently Ongoing) (Products/Services: Consultant). ● Seanergy (Currently Ongoing) (Products/Services: Consultant). ● Trifecta (Currently Ongoing) (Products/Services: Consultant). ● UCB (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● UCB (Currently Ongoing) (Products/Services: Consultant).
Randy Prescilla, MD: ● Sanofi (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Elaine C. Siegfried, Siegfried, MD: ● Regeneron (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant, Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Sanofi (Currently Ongoing) (Products/Services: Consultant, Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness).
Eric L. Simpson, MD, MCR: ● Regeneron (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant).
Yiping Sun, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
John T. O'Malley, MD, PhD: ● Sanofi-Genzyme (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Ashish Bansal, md/ma: ● Regeneron pharmaceuticals (Currently Ongoing) (Products/Services: Employment with an ineligible company).
